For pharma and medtech companies, physician segmentation is not simple classification. It is the key to precisely matching business needs. Whether clinical research needs investigators, academic promotion needs speakers, or product training needs core users, segmentation is required to identify the right people. But traditional segmentation often falls into the trap of looking only at surface information: dividing physicians only by department and title. The resulting groups look useful but fail in practice. If you want physicians familiar with a specific type of surgical device, you may only get a broad list of surgeons. If you want investigators who can join a clinical trial, you still have to manually check qualifications one by one. In fact, physician segmentation for pharma and medtech companies must solve the disconnect between data and business. MeDomino, which focuses on digital intelligence for life sciences, provides an actionable answer through the intelligent tagging + intelligent recommendation solution it built for a medical device company.
1. The Dilemma of Traditional Physician Segmentation: Classification Without Business Value
When many pharma and medtech companies segment physicians, they treat completing the classification as the goal, while ignoring which business need the segmentation should serve.
For example:
Looking only at basic attributes: physicians are divided by department, title, and hospital, but the company does not know who is familiar with operating its own device or who has clinical experience with similar products. When promoting a new surgical device, teams can only blindly approach surgeons, wasting significant communication cost;
Data disconnected from business: companies may hold data on physicians' academic papers and meeting records, but do not know how to connect that data with needs such as finding clinical investigators or academic speakers. To start a device clinical trial, they still rely on sales recommendations based on experience, which is inefficient and error-prone;
Segmentation is static: one segmentation result may be used for half a year, even when physicians' views, skills, and willingness to collaborate have changed. A physician who was previously willing to join training may have shifted to another field, but the segmentation list is not updated, causing resource mismatch.
The core of these dilemmas is that segmentation is not business-oriented. Pharma and medtech companies do not need a neat classification table. They need precise groups that can directly guide business actions. This requires moving beyond basic information classification toward deep segmentation driven by business needs.
2. The Core Logic of Physician Segmentation: Build the Right Tags, Segment the Right Groups, Land the Right Business
Physician segmentation for pharma and medtech companies should not exist for segmentation's sake. Its results must be directly convertible into business action. Two keys matter: building a business-fit tag system and using intelligent tools to realize segmentation value. This is exactly the core logic of MeDomino's solution.
1. Build a business-oriented tag system first, so segmentation has evidence
Tags are the foundation of segmentation, but pharma and medtech tags cannot be generic. They must fit each company's business scenario. For example, a surgical device company needs tags such as device-operation familiarity and surgery-type fit. A diagnostic equipment company needs tags such as equipment-use experience and clinical-data interpretation capability. These tags must directly connect physician data with enterprise business needs, rather than piling up irrelevant information.
When MeDomino designs tag systems for pharma and medtech companies, it never applies a generic template. It works backward from business needs to tag dimensions. If a company needs physicians who can serve as academic speakers, it designs tags such as speaker qualification and academic sharing experience. If it needs investigators for clinical trials, it adds tags such as number of clinical trial participations and related disease research direction. These tags cover not only basic attributes, but also business-related attributes. Segmentation is no longer a broad category such as surgeon or chief physician, but a precise group such as Shanghai-based physicians familiar with a specific surgical device and qualified as L1-L2 speakers, directly supporting promotion, training, and other business needs.
2. Then create dynamically adaptive segmentation, so results can be implemented
With a tag system in place, segmentation should not end after one round. It needs to adjust dynamically with business needs. Pharma and medtech scenarios change frequently: today the team may need physicians in grassroots hospitals familiar with a portable device; tomorrow it may need investigators at tertiary hospitals who can join multicenter trials. If segmentation cannot respond quickly, even refined tags are not useful.
MeDomino uses intelligent tools to make segmentation flexible and actionable. Business users no longer need to manually organize lists. They can enter the requirement directly in the system. For example, to find physicians who can conduct clinical research on a device, the system automatically combines tags such as research-direction match, clinical-trial qualification, and target-hospital coverage, quickly screening qualified groups. If requirements change, such as adding experience with similar device research, the user only needs to add a tag and the segmentation result updates in real time. This request-submission, system-segmentation, result-output process turns segmentation from a back-office classification table into a front-office business tool. Sales and marketing teams can directly use segmentation results in their work.
3. How One Medical Device Company Did It: From Having Data but Not Using It to Segmentation-Driven Business
A medical device company once faced a typical dilemma: it had integrated physician data and had created preliminary profiles, but did not know how to use segmentation to support business. To find physicians in a city familiar with its core product, the team had to manually check an orthopedic physician list one by one. To start a clinical trial, investigator screening required a five-step process that was slow and error-prone.
Later, MeDomino built an intelligent tagging platform + intelligent recommendation platform for the company, completely changing its segmentation logic:
First, it built a dedicated tag system around business needs. Instead of looking only at basic information, it added pharma- and medtech-specific tags such as product familiarity, device-operation experience, and clinical-trial participation history. For example, to find physicians who could conduct product training, the team only needed to combine tags such as product familiarity = high, training lecture experience = yes, and target city = XX, without manual screening. To find investigators suitable for a minimally invasive surgical device, the system automatically matched physicians skilled in that procedure and experienced with similar device trials, avoiding irrelevant investigator selection.
Next, the intelligent recommendation platform landed segmentation in business. Take clinical investigator selection as an example. The traditional process required defining scope, preliminary screening, qualification review, submission, and execution, with many steps and high error risk. Through the intelligent recommendation platform, business users only enter trial requirements, such as a safety trial for an orthopedic implant device. The system automatically recommends matching investigators based on segmentation results and records execution feedback, such as the physician's ability to manage trial processes and data submission efficiency. This feedback then feeds back into the tag system, making later segmentation more accurate.
In the end, physician segmentation at this company was no longer idle data, but a tool that directly drove business. Academic promotion became more precise after segmenting speakers. Clinical research investigator selection became faster. The company even used segmentation results to discover potential users, such as physicians familiar with similar devices, and pushed targeted new-product training to increase product trial rates.
4. Conclusion: The Key Is Business Orientation + Intelligent Implementation
When pharma and medtech companies segment physicians, they should stop worrying about how many categories to create and focus on whether segmentation can connect with business. Traditional segmentation separates data from business. MeDomino's solution essentially uses intelligent tags to bind data and business together, and intelligent recommendations to turn segmentation results into business actions. Segmentation shifts from back-office work into a front-office tool, so every segmentation round directly supports finding the right people and doing the right things.
For pharma and medtech companies, physician segmentation is not a technical task but a business task. Only when segmentation precisely supports clinical research, academic promotion, product training, and other needs, and when results can be quickly implemented through intelligent tools, can its precision value truly emerge. This is the core of MeDomino's enablement for pharma and medtech companies: not just providing a segmentation tool, but helping enterprises build a closed loop where data drives segmentation and segmentation drives business. Physician segmentation then stops being decorative and becomes a precise lever for business growth.
